
Opinion|Videos|August 9, 2024
Understanding Prescription Digital Therapeutics: Definition, FDA Review and Clinical Impact
Author(s)Arwen Podesta, MD
Arwen Podesta, MD, defines what prescription digital therapeutics (PDTs) are, describes how they differ from nonprescription digital health tools, and details the FDA review process for PDTs.
Advertisement
Episodes in this series

Now Playing
Can you define what prescription digital therapeutics (PDTs) are and describe how they differ from nonprescription digital health tools?
What is the FDA review process for PDTs, and how is it different from the review process for prescription drugs and medical devices? How does FDA authorization of a PDT factor into clinical decision-making about a treatment?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
PSG: Specialty drug spending predicted to increase 32% by 2028
4
CMS sets the 2027 Part D bid amount at $296.05, will end premium subsidy program
5





















